Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Real-World Use of FLT3 Tyrosine Kinase Inhibitors in Patients with Relapsed/Refractory FLT3 mutation-Positive Acute Myeloid Leukemia in the United States

David L. Grinblatt, Wei Han, David Nimke, Qi Feng, Loretta Sullivan, Bhavik J. Pandya

Blood (2021) 138 (Supplement 1): 5033.

https://doi.org/10.1182/blood-2021-145387

Published: 2021

Journal Articles

First Salvage Therapy for Relapsed or Refractory Acute Myeloid Leukemia: Associated Health Care Resource Use and Costs

Lori Muffly, Christopher Young, David Nimke, Loretta Sullivan, Qi Feng, Bhavik J. Pandya

Blood (2021) 138 (Supplement 1): 1936.

https://doi.org/10.1182/blood-2021-145397

Published: 2021

Journal Articles

Real-World Use of FLT3-TKIs in R/R FLT3-M utated AML in the United States

David L. Grinblatt, MD, Bhavik J. Pandya, PharmD, Wei Han, PhD, Loretta Sullivan, MD MPH, Qi Feng, PhD MS, Nancy Hedlund, PhD MBA, RPh

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136391

Published: 2020

Journal Articles

Streamline - Retrospective Cohort Study of Relapsed or Refractory (R/R) FLT3 -Mutated Acute Myeloid Leukemia (AML): Real-World Treatment, Testing Patterns, and Outcomes

Amer M. Zeidan, MBBS, MHS, Adrienne M. Gilligan, PhD, Santosh Gautam, PhD, David L. Grinblatt, MD, Dina Elsouda, Loretta Sullivan, MD MPH, Bhavik J. Pandya, PharmD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136366

Published: 2020